Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Monocyte chemotactic protein-3.

P Menten1, A Wuyts, J Van Damme

  • 1Laboratory of Molecular Immunology, Rega Institute for Medical Research, Minderbroedersstraat 10, B-3000 Leuven, Belgium.

European Cytokine Network
|January 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Navigating Penile Metastases: Personalized Management in a Rare Oncologic Challenge.

Case reports in urology·2025
Same author

Advanced CMOS manufacturing of superconducting qubits on 300 mm wafers.

Nature·2024
Same author

Prognostic significance of PI-RADS 5 lesions in patients treated by radical prostatectomy.

World journal of urology·2023
Same author

Association of alcohol control policies with adolescent alcohol consumption and with social inequality in adolescent alcohol consumption: A multilevel study in 33 countries and regions.

The International journal on drug policy·2020
Same author

Monocytes from patients with Primary Ciliary Dyskinesia show enhanced inflammatory properties and produce higher levels of pro-inflammatory cytokines.

Scientific reports·2017
Same author

[Outpatient management of pulmonary embolism diagnosed in emergency services].

Annales de cardiologie et d'angeiologie·2016
Same journal

Co-expression of CCR7 and H3K9me3 identifies aggressive B-cell lymphoma with bone marrow infiltration and poor prognosis.

European cytokine network·2026
Same journal

Re-evaluating cytokine storm syndromes: dysregulated host defense or contextual immune adaptation?

European cytokine network·2026
Same journal

Propolis as a potential modulator of aryl hydrocarbon receptor signaling in inflammation.

European cytokine network·2026
Same journal

Association between interleukin-6 promoter polymorphisms and osteoporosis in javanese postmenopausal women.

European cytokine network·2026
Same journal

Study of interferon-stimulated gene 15 expression in the medulloblastoma context.

European cytokine network·2026
Same journal

Astilbin ameliorates propranolol-induced psoriasis-like lesions through restoring Th17/Treg immune homeostasis in lymph nodes.

European cytokine network·2026
See all related articles

Monocyte chemotactic protein-3 (MCP-3), a pluripotent chemokine, activates all leukocytes by binding to multiple receptors. This inducible protein may be crucial in homeostasis and diseases like cancer and inflammation.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Monocyte chemotactic protein-3 (MCP-3) is part of the CC chemokine family, sharing structural similarities but differing in receptor interactions and functions.
  • Chemokines are vital signaling proteins that regulate immune cell migration and function.

Purpose of the Study:

  • To elucidate the broad biological activities and potential roles of Monocyte chemotactic protein-3 (MCP-3).
  • To highlight MCP-3's significance in both physiological processes and pathological conditions.

Main Methods:

  • Analysis of MCP-3's structural characteristics and receptor binding affinities.
  • Investigation of MCP-3 induction by various endogenous and exogenous stimuli.
  • Review of existing literature on MCP-3's involvement in different biological contexts.

Related Experiment Videos

Main Results:

  • MCP-3 demonstrates significant pluripotent activity, activating all leukocyte types through binding to at least four distinct chemokine receptors.
  • The natural MCP-3 protein exhibits heterogeneity due to post-translational modifications like glycosylation and N-terminal processing.
  • MCP-3 induction occurs in small quantities across various cell types in response to cytokines, bacteria, or viruses.

Conclusions:

  • MCP-3's omnipotent and inducible nature suggests a critical role in maintaining normal immune homeostasis.
  • This chemokine may significantly contribute to the pathogenesis of various diseases, including cancer, autoimmune disorders, and chronic inflammatory conditions.